Feng Peng Selected Research

Feng Peng Research Topics

Disease

78	Neoplasms (Cancer) 04/2024 - 02/2002
21	Neoplasm Metastasis (Metastasis) 01/2024 - 04/2010
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 10/2011
14	Carcinoma (Carcinomatosis) 10/2022 - 05/2004
13	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 01/2014
10	Carcinogenesis 01/2024 - 01/2009
9	Infections 03/2023 - 08/2015
8	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 01/2018
8	Lung Neoplasms (Lung Cancer) 05/2023 - 12/2004
8	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 12/2011
8	Adenocarcinoma of Lung 01/2021 - 07/2017
6	Esophageal Squamous Cell Carcinoma 12/2023 - 09/2016
6	Fibrosis (Cirrhosis) 12/2023 - 01/2014
6	Hypertension (High Blood Pressure) 01/2023 - 04/2013
6	Stomach Neoplasms (Stomach Cancer) 10/2022 - 01/2017
5	Osteosarcoma (Osteogenic Sarcoma) 03/2024 - 11/2022
5	Inflammation (Inflammations) 12/2023 - 12/2016
4	Diabetes Mellitus 11/2021 - 01/2018
4	Colonic Neoplasms (Colon Cancer) 04/2018 - 06/2005
4	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 06/2012
4	Essential Hypertension 01/2017 - 11/2002
3	Lymphatic Metastasis 04/2024 - 01/2018
3	Bacterial Infections (Bacterial Infection) 12/2023 - 02/2021
3	Melanoma (Melanoma, Malignant) 01/2023 - 01/2009
3	Cholangiocarcinoma 01/2022 - 08/2017
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 02/2017
3	Brain Neoplasms (Brain Tumor) 12/2020 - 09/2013
3	Disease Progression 01/2020 - 08/2013
3	Hyperglycemia 06/2019 - 02/2017
2	Chronic Renal Insufficiency 03/2024 - 04/2018
2	Myocardial Infarction 01/2024 - 01/2023
2	Bone Diseases (Bone Disease) 12/2023 - 01/2023
2	Poisoning 11/2023 - 05/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 08/2023 - 02/2015
2	Residual Neoplasm 02/2023 - 02/2015
2	Stroke (Strokes) 01/2023 - 01/2018
2	Heart Failure 01/2023 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2022 - 03/2017
2	Necrosis 09/2022 - 06/2005

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2003
10	Long Noncoding RNAIBA 01/2022 - 08/2017
9	ErbB Receptors (EGF Receptor)IBA 04/2024 - 03/2003
8	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 11/2002
7	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2011
7	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2005
7	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2016
6	AlloysIBA 08/2023 - 12/2016
6	Blood Glucose (Blood Sugar)IBA 01/2020 - 10/2016
6	VaccinesIBA 01/2020 - 02/2002
5	MagnesiumIBA 12/2023 - 12/2016
5	Small Interfering RNA (siRNA)IBA 06/2015 - 01/2009
4	Therapeutic UsesIBA 12/2023 - 12/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 02/2015
4	hydroxide ionIBA 08/2023 - 12/2016
4	Triglycerides (Triacylglycerol)IBA 11/2021 - 11/2002
4	Gefitinib (Iressa)FDA Link 12/2020 - 01/2012
4	Immunoglobulin G (IgG)IBA 09/2020 - 03/2003
4	LipidsIBA 08/2019 - 01/2018
4	Polysaccharides (Glycans)IBA 04/2018 - 04/2014
4	AntigensIBA 08/2007 - 02/2002
3	CytokinesIBA 12/2023 - 10/2011
3	Biocompatible Materials (Biomaterials)IBA 03/2023 - 04/2021
3	Messenger RNA (mRNA)IBA 09/2022 - 01/2020
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 12/2011
3	CateninsIBA 01/2022 - 01/2018
3	PlatinumIBA 01/2021 - 05/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 02/2015
3	CrizotinibIBA 01/2020 - 11/2017
3	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 08/2006
3	RNA (Ribonucleic Acid)IBA 03/2019 - 02/2012
3	hepatitis B virus X proteinIBA 01/2019 - 01/2017
3	CreatinineIBA 01/2019 - 07/2014
3	LigandsIBA 01/2016 - 02/2002
3	AutoantibodiesIBA 01/2014 - 02/2002
3	Immunoglobulins (Immunoglobulin)IBA 11/2004 - 02/2002
2	Immune Checkpoint InhibitorsIBA 04/2024 - 09/2019
2	Caspase 3 (Caspase-3)IBA 12/2023 - 01/2022
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2023 - 01/2020
2	ImmunosorbentsIBA 12/2023 - 02/2016
2	EnzymesIBA 12/2023 - 02/2016
2	6-methyladenineIBA 10/2023 - 01/2020
2	CopperIBA 01/2023 - 01/2023
2	Glutathione (Reduced Glutathione)IBA 01/2023 - 01/2022
2	OxidesIBA 01/2023 - 10/2022
2	MetalsIBA 01/2023 - 01/2017
2	nitinolIBA 10/2022 - 01/2022
2	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 01/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2022 - 01/2018

Therapy/Procedure

45	Therapeutics 04/2024 - 02/2002
16	Drug Therapy (Chemotherapy) 02/2023 - 12/2004
12	Radiotherapy 06/2023 - 12/2004
7	Pancreaticoduodenectomy 04/2024 - 10/2013
7	Gastrectomy 10/2022 - 01/2017
3	Immunotherapy 04/2024 - 09/2003
3	Stents 03/2024 - 09/2016
3	Liver Transplantation 04/2019 - 08/2015
2	Electrodes (Electrode) 03/2024 - 05/2015
2	Palliative Care (Palliative Therapy) 02/2023 - 09/2016
2	Semiconductors 02/2023 - 10/2022